Global Remicade Biosimilar Market Report 2019, Competitive Landscape, Trends and Opportunities
The Remicade Biosimilar market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.
The report mainly studies the size, recent trends and development status of the Remicade Biosimilar market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Remicade Biosimilar market.
Major players in the global Remicade Biosimilar market include:
LG Life Sciences
Biogen idec Inc.
Merck Serono (Merck Group)
Novartis (Sandoz)
Synthon Pharmaceuticals
Genentech (Roche Group)
Hospira
Celltrion
Teva Pharmaceutical Industries
Biocon
On the basis of types, the Remicade Biosimilar market is primarily split into:
100mg/10ml
500mg/50ml
On the basis of applications, the market covers:
Blood Disorders
Oncology Diseases
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Remicade Biosimilar market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Remicade Biosimilar market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Remicade Biosimilar industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Remicade Biosimilar market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Remicade Biosimilar, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Remicade Biosimilar in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Remicade Biosimilar in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Remicade Biosimilar. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Remicade Biosimilar market, including the global production and revenue forecast, regional forecast. It also foresees the Remicade Biosimilar market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
The report mainly studies the size, recent trends and development status of the Remicade Biosimilar market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Remicade Biosimilar market.
Major players in the global Remicade Biosimilar market include:
LG Life Sciences
Biogen idec Inc.
Merck Serono (Merck Group)
Novartis (Sandoz)
Synthon Pharmaceuticals
Genentech (Roche Group)
Hospira
Celltrion
Teva Pharmaceutical Industries
Biocon
On the basis of types, the Remicade Biosimilar market is primarily split into:
100mg/10ml
500mg/50ml
On the basis of applications, the market covers:
Blood Disorders
Oncology Diseases
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Remicade Biosimilar market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Remicade Biosimilar market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Remicade Biosimilar industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Remicade Biosimilar market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Remicade Biosimilar, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Remicade Biosimilar in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Remicade Biosimilar in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Remicade Biosimilar. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Remicade Biosimilar market, including the global production and revenue forecast, regional forecast. It also foresees the Remicade Biosimilar market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
- Historical Years: 2014-2018
- Base Year: 2019
- Estimated Year: 2019
- Forecast Period: 2019-2026
1 REMICADE BIOSIMILAR MARKET OVERVIEW
1.1 Product Overview and Scope of Remicade Biosimilar
1.2 Remicade Biosimilar Segment by Type
1.2.1 Global Remicade Biosimilar Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of 100mg/10ml
1.2.3 The Market Profile of 500mg/50ml
1.3 Global Remicade Biosimilar Segment by Application
1.3.1 Remicade Biosimilar Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Blood Disorders
1.3.3 The Market Profile of Oncology Diseases
1.4 Global Remicade Biosimilar Market by Region (2014-2026)
1.4.1 Global Remicade Biosimilar Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.3 Europe Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.3.1 Germany Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.3.2 UK Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.3.3 France Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.3.4 Italy Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.3.5 Spain Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.3.6 Russia Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.3.7 Poland Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.4 China Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.5 Japan Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.6 India Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.8 Central and South America Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Remicade Biosimilar Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Remicade Biosimilar (2014-2026)
1.5.1 Global Remicade Biosimilar Revenue Status and Outlook (2014-2026)
1.5.2 Global Remicade Biosimilar Production Status and Outlook (2014-2026)
2 GLOBAL REMICADE BIOSIMILAR MARKET LANDSCAPE BY PLAYER
2.1 Global Remicade Biosimilar Production and Share by Player (2014-2019)
2.2 Global Remicade Biosimilar Revenue and Market Share by Player (2014-2019)
2.3 Global Remicade Biosimilar Average Price by Player (2014-2019)
2.4 Remicade Biosimilar Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Remicade Biosimilar Market Competitive Situation and Trends
2.5.1 Remicade Biosimilar Market Concentration Rate
2.5.2 Remicade Biosimilar Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 LG Life Sciences
3.1.1 LG Life Sciences Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Remicade Biosimilar Product Profiles, Application and Specification
3.1.3 LG Life Sciences Remicade Biosimilar Market Performance (2014-2019)
3.1.4 LG Life Sciences Business Overview
3.2 Biogen idec Inc.
3.2.1 Biogen idec Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Remicade Biosimilar Product Profiles, Application and Specification
3.2.3 Biogen idec Inc. Remicade Biosimilar Market Performance (2014-2019)
3.2.4 Biogen idec Inc. Business Overview
3.3 Merck Serono (Merck Group)
3.3.1 Merck Serono (Merck Group) Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Remicade Biosimilar Product Profiles, Application and Specification
3.3.3 Merck Serono (Merck Group) Remicade Biosimilar Market Performance (2014-2019)
3.3.4 Merck Serono (Merck Group) Business Overview
3.4 Novartis (Sandoz)
3.4.1 Novartis (Sandoz) Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Remicade Biosimilar Product Profiles, Application and Specification
3.4.3 Novartis (Sandoz) Remicade Biosimilar Market Performance (2014-2019)
3.4.4 Novartis (Sandoz) Business Overview
3.5 Synthon Pharmaceuticals
3.5.1 Synthon Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Remicade Biosimilar Product Profiles, Application and Specification
3.5.3 Synthon Pharmaceuticals Remicade Biosimilar Market Performance (2014-2019)
3.5.4 Synthon Pharmaceuticals Business Overview
3.6 Genentech (Roche Group)
3.6.1 Genentech (Roche Group) Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Remicade Biosimilar Product Profiles, Application and Specification
3.6.3 Genentech (Roche Group) Remicade Biosimilar Market Performance (2014-2019)
3.6.4 Genentech (Roche Group) Business Overview
3.7 Hospira
3.7.1 Hospira Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Remicade Biosimilar Product Profiles, Application and Specification
3.7.3 Hospira Remicade Biosimilar Market Performance (2014-2019)
3.7.4 Hospira Business Overview
3.8 Celltrion
3.8.1 Celltrion Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Remicade Biosimilar Product Profiles, Application and Specification
3.8.3 Celltrion Remicade Biosimilar Market Performance (2014-2019)
3.8.4 Celltrion Business Overview
3.9 Teva Pharmaceutical Industries
3.9.1 Teva Pharmaceutical Industries Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Remicade Biosimilar Product Profiles, Application and Specification
3.9.3 Teva Pharmaceutical Industries Remicade Biosimilar Market Performance (2014-2019)
3.9.4 Teva Pharmaceutical Industries Business Overview
3.10 Biocon
3.10.1 Biocon Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Remicade Biosimilar Product Profiles, Application and Specification
3.10.3 Biocon Remicade Biosimilar Market Performance (2014-2019)
3.10.4 Biocon Business Overview
4 GLOBAL REMICADE BIOSIMILAR PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Remicade Biosimilar Production and Market Share by Type (2014-2019)
4.2 Global Remicade Biosimilar Revenue and Market Share by Type (2014-2019)
4.3 Global Remicade Biosimilar Price by Type (2014-2019)
4.4 Global Remicade Biosimilar Production Growth Rate by Type (2014-2019)
4.4.1 Global Remicade Biosimilar Production Growth Rate of 100mg/10ml (2014-2019)
4.4.2 Global Remicade Biosimilar Production Growth Rate of 500mg/50ml (2014-2019)
5 GLOBAL REMICADE BIOSIMILAR MARKET ANALYSIS BY APPLICATION
5.1 Global Remicade Biosimilar Consumption and Market Share by Application (2014-2019)
5.2 Global Remicade Biosimilar Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Remicade Biosimilar Consumption Growth Rate of Blood Disorders (2014-2019)
5.2.2 Global Remicade Biosimilar Consumption Growth Rate of Oncology Diseases (2014-2019)
6 GLOBAL REMICADE BIOSIMILAR PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Remicade Biosimilar Consumption by Region (2014-2019)
6.2 United States Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
6.3 Europe Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
6.4 China Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
6.5 Japan Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
6.6 India Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
7 GLOBAL REMICADE BIOSIMILAR PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Remicade Biosimilar Production and Market Share by Region (2014-2019)
7.2 Global Remicade Biosimilar Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
8 REMICADE BIOSIMILAR MANUFACTURING ANALYSIS
8.1 Remicade Biosimilar Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Remicade Biosimilar
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Remicade Biosimilar Industrial Chain Analysis
9.2 Raw Materials Sources of Remicade Biosimilar Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Remicade Biosimilar
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter’s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL REMICADE BIOSIMILAR MARKET FORECAST (2019-2026)
11.1 Global Remicade Biosimilar Production, Revenue Forecast (2019-2026)
11.1.1 Global Remicade Biosimilar Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Remicade Biosimilar Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Remicade Biosimilar Price and Trend Forecast (2019-2026)
11.2 Global Remicade Biosimilar Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Remicade Biosimilar Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Remicade Biosimilar Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
1.1 Product Overview and Scope of Remicade Biosimilar
1.2 Remicade Biosimilar Segment by Type
1.2.1 Global Remicade Biosimilar Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of 100mg/10ml
1.2.3 The Market Profile of 500mg/50ml
1.3 Global Remicade Biosimilar Segment by Application
1.3.1 Remicade Biosimilar Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Blood Disorders
1.3.3 The Market Profile of Oncology Diseases
1.4 Global Remicade Biosimilar Market by Region (2014-2026)
1.4.1 Global Remicade Biosimilar Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.3 Europe Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.3.1 Germany Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.3.2 UK Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.3.3 France Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.3.4 Italy Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.3.5 Spain Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.3.6 Russia Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.3.7 Poland Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.4 China Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.5 Japan Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.6 India Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.8 Central and South America Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Remicade Biosimilar Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Remicade Biosimilar Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Remicade Biosimilar (2014-2026)
1.5.1 Global Remicade Biosimilar Revenue Status and Outlook (2014-2026)
1.5.2 Global Remicade Biosimilar Production Status and Outlook (2014-2026)
2 GLOBAL REMICADE BIOSIMILAR MARKET LANDSCAPE BY PLAYER
2.1 Global Remicade Biosimilar Production and Share by Player (2014-2019)
2.2 Global Remicade Biosimilar Revenue and Market Share by Player (2014-2019)
2.3 Global Remicade Biosimilar Average Price by Player (2014-2019)
2.4 Remicade Biosimilar Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Remicade Biosimilar Market Competitive Situation and Trends
2.5.1 Remicade Biosimilar Market Concentration Rate
2.5.2 Remicade Biosimilar Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 LG Life Sciences
3.1.1 LG Life Sciences Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Remicade Biosimilar Product Profiles, Application and Specification
3.1.3 LG Life Sciences Remicade Biosimilar Market Performance (2014-2019)
3.1.4 LG Life Sciences Business Overview
3.2 Biogen idec Inc.
3.2.1 Biogen idec Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Remicade Biosimilar Product Profiles, Application and Specification
3.2.3 Biogen idec Inc. Remicade Biosimilar Market Performance (2014-2019)
3.2.4 Biogen idec Inc. Business Overview
3.3 Merck Serono (Merck Group)
3.3.1 Merck Serono (Merck Group) Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Remicade Biosimilar Product Profiles, Application and Specification
3.3.3 Merck Serono (Merck Group) Remicade Biosimilar Market Performance (2014-2019)
3.3.4 Merck Serono (Merck Group) Business Overview
3.4 Novartis (Sandoz)
3.4.1 Novartis (Sandoz) Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Remicade Biosimilar Product Profiles, Application and Specification
3.4.3 Novartis (Sandoz) Remicade Biosimilar Market Performance (2014-2019)
3.4.4 Novartis (Sandoz) Business Overview
3.5 Synthon Pharmaceuticals
3.5.1 Synthon Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Remicade Biosimilar Product Profiles, Application and Specification
3.5.3 Synthon Pharmaceuticals Remicade Biosimilar Market Performance (2014-2019)
3.5.4 Synthon Pharmaceuticals Business Overview
3.6 Genentech (Roche Group)
3.6.1 Genentech (Roche Group) Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Remicade Biosimilar Product Profiles, Application and Specification
3.6.3 Genentech (Roche Group) Remicade Biosimilar Market Performance (2014-2019)
3.6.4 Genentech (Roche Group) Business Overview
3.7 Hospira
3.7.1 Hospira Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Remicade Biosimilar Product Profiles, Application and Specification
3.7.3 Hospira Remicade Biosimilar Market Performance (2014-2019)
3.7.4 Hospira Business Overview
3.8 Celltrion
3.8.1 Celltrion Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Remicade Biosimilar Product Profiles, Application and Specification
3.8.3 Celltrion Remicade Biosimilar Market Performance (2014-2019)
3.8.4 Celltrion Business Overview
3.9 Teva Pharmaceutical Industries
3.9.1 Teva Pharmaceutical Industries Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Remicade Biosimilar Product Profiles, Application and Specification
3.9.3 Teva Pharmaceutical Industries Remicade Biosimilar Market Performance (2014-2019)
3.9.4 Teva Pharmaceutical Industries Business Overview
3.10 Biocon
3.10.1 Biocon Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Remicade Biosimilar Product Profiles, Application and Specification
3.10.3 Biocon Remicade Biosimilar Market Performance (2014-2019)
3.10.4 Biocon Business Overview
4 GLOBAL REMICADE BIOSIMILAR PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Remicade Biosimilar Production and Market Share by Type (2014-2019)
4.2 Global Remicade Biosimilar Revenue and Market Share by Type (2014-2019)
4.3 Global Remicade Biosimilar Price by Type (2014-2019)
4.4 Global Remicade Biosimilar Production Growth Rate by Type (2014-2019)
4.4.1 Global Remicade Biosimilar Production Growth Rate of 100mg/10ml (2014-2019)
4.4.2 Global Remicade Biosimilar Production Growth Rate of 500mg/50ml (2014-2019)
5 GLOBAL REMICADE BIOSIMILAR MARKET ANALYSIS BY APPLICATION
5.1 Global Remicade Biosimilar Consumption and Market Share by Application (2014-2019)
5.2 Global Remicade Biosimilar Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Remicade Biosimilar Consumption Growth Rate of Blood Disorders (2014-2019)
5.2.2 Global Remicade Biosimilar Consumption Growth Rate of Oncology Diseases (2014-2019)
6 GLOBAL REMICADE BIOSIMILAR PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Remicade Biosimilar Consumption by Region (2014-2019)
6.2 United States Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
6.3 Europe Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
6.4 China Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
6.5 Japan Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
6.6 India Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
7 GLOBAL REMICADE BIOSIMILAR PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Remicade Biosimilar Production and Market Share by Region (2014-2019)
7.2 Global Remicade Biosimilar Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
8 REMICADE BIOSIMILAR MANUFACTURING ANALYSIS
8.1 Remicade Biosimilar Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Remicade Biosimilar
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Remicade Biosimilar Industrial Chain Analysis
9.2 Raw Materials Sources of Remicade Biosimilar Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Remicade Biosimilar
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter’s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL REMICADE BIOSIMILAR MARKET FORECAST (2019-2026)
11.1 Global Remicade Biosimilar Production, Revenue Forecast (2019-2026)
11.1.1 Global Remicade Biosimilar Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Remicade Biosimilar Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Remicade Biosimilar Price and Trend Forecast (2019-2026)
11.2 Global Remicade Biosimilar Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Remicade Biosimilar Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Remicade Biosimilar Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Remicade Biosimilar Product Picture
Table Global Remicade Biosimilar Production and CAGR (%) Comparison by Type
Table Profile of 100mg/10ml
Table Profile of 500mg/50ml
Table Remicade Biosimilar Consumption (Sales) Comparison by Application (2014-2026)
Table Profile of Blood Disorders
Table Profile of Oncology Diseases
Figure Global Remicade Biosimilar Market Size (Value) and CAGR (%) (2014-2026)
Figure United States Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Europe Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Germany Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure UK Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure France Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Italy Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Spain Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Russia Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Poland Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure China Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Japan Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure India Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Southeast Asia Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Malaysia Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Singapore Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Philippines Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Indonesia Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Thailand Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Vietnam Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Central and South America Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Brazil Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Mexico Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Colombia Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Middle East and Africa Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Saudi Arabia Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure United Arab Emirates Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Turkey Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Egypt Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure South Africa Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Nigeria Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Global Remicade Biosimilar Production Status and Outlook (2014-2026)
Table Global Remicade Biosimilar Production by Player (2014-2019)
Table Global Remicade Biosimilar Production Share by Player (2014-2019)
Figure Global Remicade Biosimilar Production Share by Player in 2018
Table Remicade Biosimilar Revenue by Player (2014-2019)
Table Remicade Biosimilar Revenue Market Share by Player (2014-2019)
Table Remicade Biosimilar Price by Player (2014-2019)
Table Remicade Biosimilar Manufacturing Base Distribution and Sales Area by Player
Table Remicade Biosimilar Product Type by Player
Table Mergers & Acquisitions, Expansion Plans
Table LG Life Sciences Profile
Table LG Life Sciences Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Biogen idec Inc. Profile
Table Biogen idec Inc. Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Merck Serono (Merck Group) Profile
Table Merck Serono (Merck Group) Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Novartis (Sandoz) Profile
Table Novartis (Sandoz) Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Synthon Pharmaceuticals Profile
Table Synthon Pharmaceuticals Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Genentech (Roche Group) Profile
Table Genentech (Roche Group) Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Hospira Profile
Table Hospira Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Celltrion Profile
Table Celltrion Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Profile
Table Teva Pharmaceutical Industries Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Biocon Profile
Table Biocon Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Global Remicade Biosimilar Production by Type (2014-2019)
Table Global Remicade Biosimilar Production Market Share by Type (2014-2019)
Figure Global Remicade Biosimilar Production Market Share by Type in 2018
Table Global Remicade Biosimilar Revenue by Type (2014-2019)
Table Global Remicade Biosimilar Revenue Market Share by Type (2014-2019)
Figure Global Remicade Biosimilar Revenue Market Share by Type in 2018
Table Remicade Biosimilar Price by Type (2014-2019)
Figure Global Remicade Biosimilar Production Growth Rate of 100mg/10ml (2014-2019)
Figure Global Remicade Biosimilar Production Growth Rate of 500mg/50ml (2014-2019)
Table Global Remicade Biosimilar Consumption by Application (2014-2019)
Table Global Remicade Biosimilar Consumption Market Share by Application (2014-2019)
Table Global Remicade Biosimilar Consumption of Blood Disorders (2014-2019)
Table Global Remicade Biosimilar Consumption of Oncology Diseases (2014-2019)
Table Global Remicade Biosimilar Consumption by Region (2014-2019)
Table Global Remicade Biosimilar Consumption Market Share by Region (2014-2019)
Table United States Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
Table Europe Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
Table China Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
Table Japan Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
Table India Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
Table Southeast Asia Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
Table Central and South America Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
Table Middle East and Africa Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
Table Global Remicade Biosimilar Production by Region (2014-2019)
Table Global Remicade Biosimilar Production Market Share by Region (2014-2019)
Figure Global Remicade Biosimilar Production Market Share by Region (2014-2019)
Figure Global Remicade Biosimilar Production Market Share by Region in 2018
Table Global Remicade Biosimilar Revenue by Region (2014-2019)
Table Global Remicade Biosimilar Revenue Market Share by Region (2014-2019)
Figure Global Remicade Biosimilar Revenue Market Share by Region (2014-2019)
Figure Global Remicade Biosimilar Revenue Market Share by Region in 2018
Table Global Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table United States Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Europe Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table China Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Japan Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table India Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Southeast Asia Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Central and South America Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Middle East and Africa Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Key Raw Materials Introduction of Remicade Biosimilar
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Market Concentration Rate of Raw Materials
Figure Manufacturing Cost Structure Analysis
Figure Manufacturing Process Analysis of Remicade Biosimilar
Figure Remicade Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Remicade Biosimilar Major Players in 2018
Table Downstream Buyers
Figure Global Remicade Biosimilar Production and Growth Rate Forecast (2019-2026)
Figure Global Remicade Biosimilar Revenue and Growth Rate Forecast (2019-2026)
Figure Global Remicade Biosimilar Price and Trend Forecast (2019-2026)
Table United States Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
Table Europe Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
Table China Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
Table Japan Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
Table India Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
Table Southeast Asia Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
Table Southeast Asia Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
Table Middle East and Africa Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
Table Global Remicade Biosimilar Market Production Forecast, by Type
Table Global Remicade Biosimilar Production Volume Market Share Forecast, by Type
Table Global Remicade Biosimilar Market Revenue Forecast, by Type
Table Global Remicade Biosimilar Revenue Market Share Forecast, by Type
Table Global Remicade Biosimilar Price Forecast, by Type
Table Global Remicade Biosimilar Market Production Forecast, by Application
Table Global Remicade Biosimilar Production Volume Market Share Forecast, by Application
Table Global Remicade Biosimilar Market Revenue Forecast, by Application
Table Global Remicade Biosimilar Revenue Market Share Forecast, by Application
Table Global Remicade Biosimilar Price Forecast, by Application
Figure Remicade Biosimilar Product Picture
Table Global Remicade Biosimilar Production and CAGR (%) Comparison by Type
Table Profile of 100mg/10ml
Table Profile of 500mg/50ml
Table Remicade Biosimilar Consumption (Sales) Comparison by Application (2014-2026)
Table Profile of Blood Disorders
Table Profile of Oncology Diseases
Figure Global Remicade Biosimilar Market Size (Value) and CAGR (%) (2014-2026)
Figure United States Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Europe Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Germany Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure UK Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure France Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Italy Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Spain Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Russia Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Poland Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure China Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Japan Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure India Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Southeast Asia Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Malaysia Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Singapore Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Philippines Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Indonesia Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Thailand Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Vietnam Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Central and South America Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Brazil Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Mexico Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Colombia Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Middle East and Africa Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Saudi Arabia Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure United Arab Emirates Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Turkey Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Egypt Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure South Africa Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Nigeria Remicade Biosimilar Revenue and Growth Rate (2014-2026)
Figure Global Remicade Biosimilar Production Status and Outlook (2014-2026)
Table Global Remicade Biosimilar Production by Player (2014-2019)
Table Global Remicade Biosimilar Production Share by Player (2014-2019)
Figure Global Remicade Biosimilar Production Share by Player in 2018
Table Remicade Biosimilar Revenue by Player (2014-2019)
Table Remicade Biosimilar Revenue Market Share by Player (2014-2019)
Table Remicade Biosimilar Price by Player (2014-2019)
Table Remicade Biosimilar Manufacturing Base Distribution and Sales Area by Player
Table Remicade Biosimilar Product Type by Player
Table Mergers & Acquisitions, Expansion Plans
Table LG Life Sciences Profile
Table LG Life Sciences Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Biogen idec Inc. Profile
Table Biogen idec Inc. Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Merck Serono (Merck Group) Profile
Table Merck Serono (Merck Group) Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Novartis (Sandoz) Profile
Table Novartis (Sandoz) Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Synthon Pharmaceuticals Profile
Table Synthon Pharmaceuticals Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Genentech (Roche Group) Profile
Table Genentech (Roche Group) Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Hospira Profile
Table Hospira Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Celltrion Profile
Table Celltrion Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Profile
Table Teva Pharmaceutical Industries Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Biocon Profile
Table Biocon Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Global Remicade Biosimilar Production by Type (2014-2019)
Table Global Remicade Biosimilar Production Market Share by Type (2014-2019)
Figure Global Remicade Biosimilar Production Market Share by Type in 2018
Table Global Remicade Biosimilar Revenue by Type (2014-2019)
Table Global Remicade Biosimilar Revenue Market Share by Type (2014-2019)
Figure Global Remicade Biosimilar Revenue Market Share by Type in 2018
Table Remicade Biosimilar Price by Type (2014-2019)
Figure Global Remicade Biosimilar Production Growth Rate of 100mg/10ml (2014-2019)
Figure Global Remicade Biosimilar Production Growth Rate of 500mg/50ml (2014-2019)
Table Global Remicade Biosimilar Consumption by Application (2014-2019)
Table Global Remicade Biosimilar Consumption Market Share by Application (2014-2019)
Table Global Remicade Biosimilar Consumption of Blood Disorders (2014-2019)
Table Global Remicade Biosimilar Consumption of Oncology Diseases (2014-2019)
Table Global Remicade Biosimilar Consumption by Region (2014-2019)
Table Global Remicade Biosimilar Consumption Market Share by Region (2014-2019)
Table United States Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
Table Europe Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
Table China Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
Table Japan Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
Table India Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
Table Southeast Asia Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
Table Central and South America Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
Table Middle East and Africa Remicade Biosimilar Production, Consumption, Export, Import (2014-2019)
Table Global Remicade Biosimilar Production by Region (2014-2019)
Table Global Remicade Biosimilar Production Market Share by Region (2014-2019)
Figure Global Remicade Biosimilar Production Market Share by Region (2014-2019)
Figure Global Remicade Biosimilar Production Market Share by Region in 2018
Table Global Remicade Biosimilar Revenue by Region (2014-2019)
Table Global Remicade Biosimilar Revenue Market Share by Region (2014-2019)
Figure Global Remicade Biosimilar Revenue Market Share by Region (2014-2019)
Figure Global Remicade Biosimilar Revenue Market Share by Region in 2018
Table Global Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table United States Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Europe Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table China Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Japan Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table India Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Southeast Asia Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Central and South America Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Middle East and Africa Remicade Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
Table Key Raw Materials Introduction of Remicade Biosimilar
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Market Concentration Rate of Raw Materials
Figure Manufacturing Cost Structure Analysis
Figure Manufacturing Process Analysis of Remicade Biosimilar
Figure Remicade Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Remicade Biosimilar Major Players in 2018
Table Downstream Buyers
Figure Global Remicade Biosimilar Production and Growth Rate Forecast (2019-2026)
Figure Global Remicade Biosimilar Revenue and Growth Rate Forecast (2019-2026)
Figure Global Remicade Biosimilar Price and Trend Forecast (2019-2026)
Table United States Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
Table Europe Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
Table China Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
Table Japan Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
Table India Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
Table Southeast Asia Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
Table Southeast Asia Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
Table Middle East and Africa Remicade Biosimilar Production, Consumption, Export and Import Forecast (2019-2026)
Table Global Remicade Biosimilar Market Production Forecast, by Type
Table Global Remicade Biosimilar Production Volume Market Share Forecast, by Type
Table Global Remicade Biosimilar Market Revenue Forecast, by Type
Table Global Remicade Biosimilar Revenue Market Share Forecast, by Type
Table Global Remicade Biosimilar Price Forecast, by Type
Table Global Remicade Biosimilar Market Production Forecast, by Application
Table Global Remicade Biosimilar Production Volume Market Share Forecast, by Application
Table Global Remicade Biosimilar Market Revenue Forecast, by Application
Table Global Remicade Biosimilar Revenue Market Share Forecast, by Application
Table Global Remicade Biosimilar Price Forecast, by Application
